Diagnosis of peritoneal invasion, lymph node metastasis, and hepatic metastasis is crucial in the decision-making process of ovarian tumor treatment. This study aimed to test the feasibility of low-dose abdominopelvic CT with an artificial intelligence iterative reconstruction (AIIR) for diagnosing peritoneal invasion, lymph node metastasis, and hepatic metastasis in pre-operative imaging of ovarian tumor. This study prospectively enrolled 88 patients with pathology-confirmed ovarian tumors, where routine-dose CT at portal venous phase (120 kVp/ref. 200 mAs) with hybrid iterative reconstruction (HIR) was followed by a low-dose scan (120 kVp/ref. 40 mAs) with AIIR. The performance of diagnosing peritoneal invasion and lymph node metastasis was assessed using receiver operating characteristic (ROC) analysis with pathological results serving as the reference. The hepatic parenchymal metastases were diagnosed and signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were measured. The perihepatic structures were also scored on the clarity of porta hepatis, gallbladder fossa and intersegmental fissure. The effective dose of low-dose CT was 79.8% lower than that of routine-dose scan (2.64 ± 0.46 vs. 13.04 ± 2.25 mSv, p < 0.001). The low-dose AIIR showed similar area under the ROC curve (AUC) with routine-dose HIR for diagnosing both peritoneal invasion (0.961 vs. 0.960, p = 0.734) and lymph node metastasis (0.711 vs. 0.715, p = 0.355). The 10 hepatic parenchymal metastases were all accurately diagnosed on the two image sets. The low-dose AIIR exhibited higher SNR and CNR for hepatic parenchymal metastases and superior clarity for perihepatic structures. In low-dose pre-operative CT of ovarian tumor, AIIR delivers similar diagnostic accuracy for peritoneal invasion, lymph node metastasis, and hepatic metastasis, as compared to routine-dose abdominopelvic CT. It is feasible and diagnostically safe to apply up to 80% dose reduction in CT imaging of ovarian tumor by using AIIR.

To evaluate the predictive ability of AI HIP in determining the size and position of prostheses during complex total hip arthroplasty (THA). Additionally, it investigates the factors influencing the accuracy of preoperative planning predictions. From April 2021 to December 2023, patients with complex hip joint diseases were divided into the AI preoperative planning group (n = 29) and the X-ray preoperative planning group (n = 27). Postoperative X-rays were used to measure acetabular anteversion angle, abduction angle, tip-to-sternum distance, intraoperative duration, blood loss, planning time, postoperative Harris Hip Scores (at 2 weeks, 3 months, and 6 months), and visual analogue scale (VAS) pain scores (at 2 weeks and at final follow-up) to analyze clinical outcomes. On the acetabular side, the accuracy of AI preoperative planning was higher compared to X-ray preoperative planning (75.9% vs. 44.4%, P = 0.016). On the femoral side, AI preoperative planning also showed higher accuracy compared to X-ray preoperative planning (85.2% vs. 59.3%, P = 0.033). The AI preoperative planning group showed superior outcomes in terms of reducing bilateral leg length discrepancy (LLD), decreasing operative time and intraoperative blood loss, early postoperative recovery, and pain control compared to the X-ray preoperative planning group (P < 0.05). No significant differences were observed between the groups regarding bilateral femoral offset (FO) differences, bilateral combined offset (CO) differences, abduction angle, anteversion angle, or tip-to-sternum distance. Factors such as gender, age, affected side, comorbidities, body mass index (BMI) classification, bone mineral density did not affect the prediction accuracy of AI HIP preoperative planning. Artificial intelligence-based 3D planning can be effectively utilized for preoperative planning in complex THA. Compared to X-ray templating, AI demonstrates superior accuracy in prosthesis measurement and provides significant clinical benefits, particularly in early postoperative recovery.

This study aims to compare the diagnostic efficiency of the American College of Radiology-Thyroid Imaging, Reporting, and Data System (ACR-TIRADS), fine-needle aspiration (FNA) cytopathology alone, and the dynamic artificial intelligence (AI) diagnostic system. A total of 1035 patients from three hospitals were included in the study. Of these, 590 were from the retrospective dataset and 445 cases were from the prospective dataset. The diagnostic accuracy of the dynamic AI system in the thyroid nodules was evaluated in comparison to the gold standard of postoperative pathology. The sensitivity, specificity, ROC, and diagnostic differences in the κ-factor relative to the gold standard were analyzed for the AI system and the FNA. The dynamic AI diagnostic system showed good diagnostic stability in different ages and sexes and nodules of different sizes. The diagnostic AUC of the dynamic AI system showed a significant improvement from 0.89 to 0.93 compared to ACR TI-RADS. Compared to that of FNA cytopathology, the diagnostic efficacy of the dynamic AI system was found to be no statistical difference in both the retrospective cohort and the prospective cohort. The dynamic AI diagnostic system enhances the accuracy of ACR TI-RADS-based diagnoses and has the potential to replace biopsies, thus reducing the necessity for invasive procedures in patients.

Efficient evaluation of soft tissues and bony structures following cervical spine trauma is critical. We sought to evaluate the diagnostic validity of magnetic resonance imaging (MRI)-based synthetic CT (sCT) compared with conventional computed tomography (CT) for cervical spine injuries. In a prospective, multicenter study, patients with cervical spine injuries underwent CT and MRI within 48 h after injury. A panel of five clinicians independently reviewed the images for diagnostic accuracy, lesion characterization (AO Spine classification), and soft tissue trauma. Fracture visibility, anterior (AVH) and posterior wall height (PVH), vertebral body angle (VBA), segmental kyphosis (SK), with corresponding interobserver reliability (intraclass correlation coefficients (ICC)) and intermodal differences (Fleiss' Kappa), were recorded. The accuracy of estimating Hounsfield unit (HU) values and mean cortical surface distances were measured. Thirty-seven patients (44 cervical spine fractures) were enrolled. sCT demonstrated a sensitivity of 97.3% for visualizing fractures. Intermodal agreement regarding injury classification indicated almost perfect agreement (κ = 0.922; p < 0.001). Inter-reader ICCs were good to excellent (CT vs. sCT): AVH (0.88, 0.87); PVH (0.87, 0.88); VBA (0.78, 0.76); SK (0.77, 0.93). Intermodal agreement showed a mean absolute difference of 0.3 mm (AVH), 0.3 mm (PVH), 1.15° (VBA) and 0.51° (SK), respectively. MRI visualized additional soft tissue trauma in 56.8% of patients. Voxelwise comparisons of sCT showed good to excellent agreement with CT in terms of HUs (mean absolute error of 20 (SD ± 62)) and a mean absolute cortical surface distance of 0.45 mm (SD ± 0.13). sCT is a promising, radiation-free imaging technique for diagnosing cervical spine injuries with similar accuracy to CT. Question Assessing the accuracy of MRI-based synthetic CT (sCT) for fracture visualization and classification in comparison to the gold standard of CT for cervical spine injuries. Findings sCT demonstrated a 97.3% sensitivity in detecting fractures and exhibited near-perfect intermodal agreement in classifying injuries according to the AO Spine classification system. Clinical relevance sCT is a promising, radiation-free imaging modality that offers comparable accuracy to CT in visualizing and classifying cervical spine injuries. The combination of conventional MRI sequences for soft tissue evaluation with sCT reconstruction for bone visualization provides comprehensive diagnostic information.

Artificial intelligence (AI) has been proposed to assist radiologists in reporting multiparametric magnetic resonance imaging (mpMRI) of the prostate. We evaluate the diagnostic performance of radiologists with different levels of experience when reporting mpMRI with the support of available AI-based software (Quantib Prostate). This is a single-center study (NCT06298305) involving 110 patients. Those with a positive mpMRI (PI-RADS ≥ 3) underwent targeted plus systematic biopsy (TBx plus SBx), while those with a negative mpMRI but a high clinical suspicion of prostate cancer (PCa) underwent SBx. Three readers with different levels of experience, identified as R1, R2, and R3 reviewed all mpMRI. Inter-reader agreement among the three readers with or without the assistance of Quantib Prostate as well as sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy for the detection of clinically significant PCa (csPCa) were assessed. 102 patients underwent prostate biopsy and the csPCa detection rate was 47%. Using Quantib Prostate resulted in an increased number of lesions identified for R3 (101 vs. 127). Inter-reader agreement slightly increased when using Quantib Prostate from 0.37 to 0.41 without vs. with Quantib Prostate, respectively. PPV, NPV and diagnostic accuracy (measured by the area under the curve [AUC]) of R3 improved (0.51 vs. 0.55, 0.65 vs.0.82 and 0.56 vs. 0.62, respectively). Conversely, no changes were observed for R1 and R2. Using Quantib Prostate did not enhance the detection rate of csPCa for readers with some experience in prostate imaging. However, for an inexperienced reader, this AI-based software is demonstrated to improve the performance. Name of registry: clinicaltrials.gov. NCT06298305. Date of registration: 2022-09.

Early detection is clinically crucial for the strategic handling of sarcopenia, yet the screening process, which includes assessments of muscle mass, strength, and function, remains complex and difficult to access. This study aims to develop a convolutional neural network model based on ultrasound images to simplify the diagnostic process and promote its accessibility. This study prospectively evaluated 357 participants (101 with sarcopenia and 256 without sarcopenia) for training, encompassing three types of data: muscle ultrasound images, clinical information, and laboratory information. Three monomodal models based on each data type were developed in the training cohort. The data type with the best diagnostic performance was selected to develop the bimodal and multimodal model by adding another one or two data types. Subsequently, the diagnostic performance of the above models was compared. The contribution ratios of different data types were further analyzed for the multimodal model. A sensitivity analysis was performed by excluding 86 cases with missing values and retaining 271 complete cases for robustness validation. By comprehensive comparison, we finally identified the optimal model (SARCO model) as the convenient solution. Moreover, the SARCO model underwent an external validation with 145 participants (68 with sarcopenia and 77 without sarcopenia) and a proof-of-concept validation with 82 participants (19 with sarcopenia and 63 without sarcopenia) from two other hospitals. The monomodal model based on ultrasound images achieved the highest area under the receiver operator characteristic curve (AUC) of 0.827 and F1-score of 0.738 among the three monomodal models. Sensitivity analysis on complete data further confirmed the superiority of the ultrasound images model (AUC: 0.851; F1-score: 0.698). The performance of the multimodal model demonstrated statistical differences compared to the best monomodal model (AUC: 0.845 vs 0.827; P=.02) as well as the two bimodal models based on ultrasound images+clinical information (AUC: 0.845 vs 0.826; P=.03) and ultrasound images+laboratory information (AUC: 0.845 vs 0.832, P=0.035). On the other hand, ultrasound images contributed the most evidence for diagnosing sarcopenia (0.787) and nonsarcopenia (0.823) in the multimodal models. Sensitivity analysis showed consistent performance trends, with ultrasound images remaining the dominant contributor (Shapley additive explanation values: 0.810 for sarcopenia and 0.795 for nonsarcopenia). After comprehensive clinical analysis, the monomodal model based on ultrasound images was identified as the SARCO model. Subsequently, the SARCO model achieved satisfactory prediction performance in the external validation and proof-of-concept validation, with AUCs of 0.801 and 0.757 and F1-scores of 0.727 and 0.666, respectively. All three types of data contributed to sarcopenia diagnosis, while ultrasound images played a dominant role in model decision-making. The SARCO model based on ultrasound images is potentially the most convenient solution for diagnosing sarcopenia. Chinese Clinical Trial Registry ChiCTR2300073651; https://www.chictr.org.cn/showproj.html?proj=199199.